Home List your patent My account Help Support us

ADJUSTABLE NASAL PASSAGE EXPANDER BREATHING STRIPS

[Category : - HEALTH- Fitness]
[Viewed 365 times]

This patented product improves nasal passage air flow., while reducing air pressure. The XPandAir Breathing Strip solution is constructed with flexible resilient material and medical grade removable and repositionalbe adhesive for the utilization with skin contact to expand the nasal passages. Beyond the inherent benefits to promote a more restful restorative sleep, XPandAir can be for sports, cold & allergy relief and even at the dentist. In addition future iterations as a promotional product, fund raising vehicle and licensed product at retail.

Financial information

American Medical Association report states:
- 45% of men & 30% of women snore regularly
- 1 in 5 adults has at least mild obstructive sleep apnea
- 1 in 15 adults has OSA of moderate or worse severity
- 18 million Americans suffer from sleep apnea
Global Sleep Market projected to reach $84.9 billion by 2021
Sleep Apnea devices are expected to grow to $27.5 billion and
the “OTC”Over the Counter Sleep Aids are forecasted to reach $1 Billion during this period

- 34% of Americans exercise frequently (100+ days a year)
- 10% exercise regularly (50-99 days a year)
- Over 108 million Americans walk for fitness
- 50 million Americans used treadmills
- 159 million Americans engage in some
type of fitness-related activity
- The nonprofit industry accounts for 5% of the nation's GDP1
- In 2009, public charities reported revenue of $1.4 trillion1
- There are 1.8 million nonprofit organizations in the U.S.
- There are over 1 Billion Colds Annually in the U.S.
- An estimated 50 million Americans suffer from all types of allergies (1 in 5 Americans) including indoor/outdoor, food & drug, latex, insect, skin and eye allergies. Allergy prevalence overall has been increasing since the early 1980s across all age, sex and racial groups. [1]
Allergy is the 5th leading chronic disease in the U.S. among all ages, and the 3rd most common chronic disease among children under 18 years old. [2]
Indoor and Outdoor Allergies – (Allergic rhinitis; seasonal/perennial allergies; hay fever; nasal allergies) Approximately 40 million Americans have indoor/outdoor allergies as their primary allergy. (Many people with allergies usually have more than one type of allergy.) Approximately 10 million people are allergic to cat dander, the most common pet allergy. The most common indoor/outdoor allergy triggers are: tree, grass and weed pollen; mold spores; dust mite and cockroach allergen; and, cat, dog and rodent dander.
Morbidity - Allergies are the most frequently reported chronic condition in children, limiting activities for more than 40% of them.
Each year, allergies account for more than 17 million outpatient office visits, primarily in the spring and fall; seasonal allergies account for more than half of all allergy visits. [3]
Social and Economic Costs - The annual cost of allergies is estimated to be nearly $14.5 billion.
Nearly 85% ($12.3 billion) is for direct costs including $1.3 billion for doctor office visits and $11 billion for medications ($7 billion prescription, $4 billion over-the-counter).
Indirect costs of allergy (missed work or school, lost productivity, death, etc.) account for approximately $2.2 billion (15%) of the total annual cost of allergies in the U.S.
For adults, allergies (hay fever) is the 5th leading chronic disease and a major cause of work absenteeism and “presenteeism,” resulting in nearly 4 million missed or lost workdays each year, resulting in a total cost of more than $700 million in total lost productivity

Patent publications:

US 8561618

US 9308114

Asking price:

Make an offer

Rate this patent

Great invention
Viewed: 365 times

Seller:

xpandair (United States)

Seller's website

Ask a question
or start a negotiation

Contact the seller

Share on social media